Payments to Acquire Property, Plant, and Equipment of NEUROCRINE BIOSCIENCES INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
NEUROCRINE BIOSCIENCES INC annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $10,700,000, a 4.5% decline year-over-year.
  • NEUROCRINE BIOSCIENCES INC annual Payments to Acquire Property, Plant, and Equipment for 2025 was $34,000,000, a 11% decline from 2024.
  • NEUROCRINE BIOSCIENCES INC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $38,200,000, a 35% increase from 2023.
  • NEUROCRINE BIOSCIENCES INC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $28,300,000, a 72% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $34,000,000 -$4,200,000 -11% 01 Jan 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
2024 $38,200,000 +$9,900,000 +35% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
2023 $28,300,000 +$11,800,000 +72% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
2022 $16,500,000 -$6,900,000 -29% 01 Jan 2022 31 Dec 2022 10-K 10 Feb 2025 2024 FY
2021 $23,400,000 +$12,500,000 +115% 01 Jan 2021 31 Dec 2021 10-K 09 Feb 2024 2023 FY
2020 $10,900,000 -$3,800,000 -26% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 $14,700,000 -$10,100,000 -41% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
2018 $24,800,000 +$17,860,000 +257% 01 Jan 2018 31 Dec 2018 10-K 05 Feb 2021 2020 FY
2017 $6,940,000 +$2,832,000 +69% 01 Jan 2017 31 Dec 2017 10-K 07 Feb 2020 2019 FY
2016 $4,108,000 +$2,174,000 +112% 01 Jan 2016 31 Dec 2016 10-K 08 Feb 2019 2018 FY
2015 $1,934,000 +$322,000 +20% 01 Jan 2015 31 Dec 2015 10-K 13 Feb 2018 2017 FY
2014 $1,612,000 +$1,067,000 +196% 01 Jan 2014 31 Dec 2014 10-K 14 Feb 2017 2016 FY
2013 $545,000 -$426,000 -44% 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2016 2015 FY
2012 $971,000 +$221,000 +29% 01 Jan 2012 31 Dec 2012 10-K 09 Feb 2015 2014 FY
2011 $750,000 +$435,000 +138% 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014 2013 FY
2010 $315,000 01 Jan 2010 31 Dec 2010 10-K 08 Feb 2013 2012 FY

NEUROCRINE BIOSCIENCES INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $10,700,000 -$500,000 -4.5% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $11,200,000 +$2,700,000 +32% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $8,500,000 +$900,000 +12% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $7,600,000 +$3,100,000 +69% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $4,500,000 +$3,200,000 +246% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $1,300,000 -$2,600,000 -67% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $3,900,000 +$2,100,000 +117% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $1,800,000 +$438,000 +32% 01 Jan 2018 31 Mar 2018 10-Q 29 Apr 2019 2019 Q1
Q1 2017 $1,362,000 +$621,000 +84% 01 Jan 2017 31 Mar 2017 10-Q 30 Apr 2018 2018 Q1
Q1 2016 $741,000 +$461,000 +165% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $280,000 +$25,000 +9.8% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $255,000 +$196,000 +332% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q1 2013 $59,000 -$345,000 -85% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q1 2012 $404,000 +$384,000 +1920% 01 Jan 2012 31 Mar 2012 10-Q 02 May 2013 2013 Q1
Q1 2011 $20,000 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.